IBB 240830 146.00C (IBB240830C146000) Stock Options, News & Quotes

2.15
-0.20-8.51%

15min DelayClose Aug 27 16:00 ET

2.15High2.05Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo Research

Aug 8 03:31

Columns Beneficiary Sectors Under Harris Policy Blueprint |Moomoo research

In the complex landscape of global political and economic affairs, Kamala Harris's emergence has undoubtedly drawn widespread attention. As the Democratic presidential candidate, her policy ideas and future plans are becoming key research subjects for markets and analysts. Harris's background, personal experiences, and her stance on various critical issues will profoundly impact the future political and economic landscape. This a...

Trump Trade vs Harris Trade: What sectors are you betting on?

Goodjobguys

Aug 1 09:43

7 Cheap But Risky Biotech Stocks? Funds moving from big corporations to Small Caps?

$Immuneering (IMRX.US)$ $SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$ $S&P 500 Index (.SPX.US)$ $BioAtla (BCAB.US)$ $Gilead Sciences (GILD.US)$ $Affimed NV (AFMD.US)$ $Instil Bio (TIL.US)$ $Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...

102718588

May 27 21:28

$iShares Biotechnology ETF (IBB.US)$
Buy this ETF before the biotechnology boom will come next time

Meltyy

Apr 10 01:22

12 Biotech M&A deals in Q1 totaling $19 bil on similar pace with 2022...

$SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$
M&A in Q1 alone totaled 12 deals for $19.2 bil which is close to the 10 deals for $21.9 bil in all the 1H of 2023...
But one big caveat of this chart, it doesn't include $Pfizer (PFE.US)$ 's $43 bil deal for $SGEN announced in Mar 2023 but didn't close until Dec bc of an FTC challenge,
The biggest biotech M&A deal so far this yr was $Gilead Sciences (GILD.US)$ 's $4.3 b...

frankinglily

Apr 9 10:01

$SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$
Observations from $VINC (-60% AH):
1- When companies tout "strong safety profile", often means efficacy is a big fat zero
2- Phrases like "dose dependent clinical activity" set the bar low
3- "Promising" doesn't necessarily refer to SP
Stay skeptical, my friends.